Takeda Pharmaceutical Company
From Wikipedia, the free encyclopedia
| Takeda Pharmaceutical Company Limited | |
|---|---|
 |
|
| Type | Public (TYO: 4502) |
| Founded | 1781 |
| Headquarters | Osaka, Japan |
| Key people | Kunio Takeda, Chairman Yasuchika Hasegawa, President |
| Industry | Pharmaceuticals |
| Revenue | ▲$10.360 billion USD (FY 2005) |
| Net income | ▲$2.677 billion USD (FY 2005) |
| Employees | 15,069 (2005) |
| Website | www.takeda.com |
Takeda Pharmaceutical Company Limited (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha?) (TYO: 4502) is the largest pharmaceutical company in Japan, with overseas business offices in Europe and in the United States. Their American subsidiary, Takeda Pharmaceuticals North America, Inc., is based in Deerfield, Illinois. Global research and development is also based in Deerfield.
One of their mainstay drugs is Actos, a compound used in the treatment of certain types of diabetes.
Takeda also owns TAP Pharmaceuticals, a joint venture with Abbott Laboratories.
In 2007, Takeda Pharmaceutical was awarded the Bad Product Award (2007 Overall Winner) by Consumers International[[1]. The company advertises the sleeping pill Rozerem to children in its "Back to School"-campaign (“Rozerem would like to remind you that it’s back to school season. Ask your doctor today if Rozerem is right for you.”) The Jury's motivation was that the advertisement ran without noting the very serious side effects that this drug can have, including increased thoughts of suicide in already depressed patients. Takeda pharmaceuticals also failed to mention the precautions on its packaging about children using this drug.
[edit] References
[edit] External links
 This article about a Japanese corporation- or company-related topic is a stub. You can help Wikipedia by expanding it. |
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
